Skip to main content
Twist Bioscience Corporation (TWST)
NASDAQ: TWST · IEX Real-Time Price · USD
31.23
-0.80 (-2.50%)
At close: Apr 30, 2024, 4:00 PM
31.30
+0.07 (0.22%)
After-hours: Apr 30, 2024, 7:10 PM EDT

Twist Bioscience Revenue

Twist Bioscience had revenue of $262.36M in the twelve months ending December 31, 2023, with 21.58% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $71.50M with 31.81% year-over-year growth. In the fiscal year ending September 30, 2023, Twist Bioscience had annual revenue of $245.11M with 20.41% growth.

Revenue (ttm)
$262.36M
Revenue Growth
+21.58%
P/S Ratio
6.80
Revenue / Employee
$285,489
Employees
919
Market Cap
1.78B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023245.11M41.54M20.41%
Sep 30, 2022203.57M71.23M53.83%
Sep 30, 2021132.33M42.23M46.87%
Sep 30, 202090.10M35.72M65.67%
Sep 30, 201954.39M28.96M113.89%
Sep 30, 201825.43M14.66M136.16%
Sep 30, 201710.77M8.50M374.53%
Sep 30, 20162.27M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BrightSpring Health Services 8.83B
Amneal Pharmaceuticals 2.39B
Astrana Health 1.39B
NeoGenomics 591.64M
Catalyst Pharmaceuticals 398.20M
Agios Pharmaceuticals 26.82M
Fusion Pharmaceuticals 2.07M
Revenue Rankings

TWST News

More News